Participation in an innovative patient support program reduces prescription abandonment for adalimumab-treated patients in a commercial population

PURPOSE: Nonadherence to indicated therapy reduces treatment effectiveness and may increase cost of care. HUMIRA Complete, a Patient Support Program (PSP), aims to reduce nonadherence in patients prescribed adalimumab (ADA). The objective of this study was to assess the relationship between particip...

Descripción completa

Detalles Bibliográficos
Autores principales: Brixner, Diana, Mittal, Manish, Rubin, David T, Mease, Philip, Liu, Harry H, Davis, Matthew, Ganguli, Arijit, Fendrick, A Mark
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750846/
https://www.ncbi.nlm.nih.gov/pubmed/31571837
http://dx.doi.org/10.2147/PPA.S215037

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750846/
https://www.ncbi.nlm.nih.gov/pubmed/31571837
http://dx.doi.org/10.2147/PPA.S215037

Ejemplares similares